Header image

Session C: Oral Abstracts

Tracks
.
Wednesday, September 6, 2017
1:00 PM - 2:20 PM
Hudson I, II & III

Speaker

Agenda Item Image
Dr Kimberly Page
Professor
University Of New Mexico Health Sciences Center

Injection Partner Mixing: Higher Risk Of HCV among Young Adults who Inject Drugs with Younger Injecting Partners

1:00 PM - 1:15 PM

Abstract

Speaker Presentation

Biography

Dr. Kimberly Page is an infectious disease epidemiologist with experience in prospective cohort studies, clinical trials and implementation science. She is a Professor and Chief of Epidemiology, Biostatistics and Preventive Medicine, in the Department of Internal Medicine at UNM HSC.
Agenda Item Image
Professor Julie Bruneau
Professor
Uiversité De Montréal

Examining The Association Between Prescription Opioid Injection And HCV Transmission During Transition of a Drug Epidemic in Montreal, Canada

1:15 PM - 1:30 PM

Abstract

Biography

Dr Julie Bruneau is Professor in the Department of Family and Emergency Medicine at Université de Montréal. She is currently Head of the Primary Care Department at the Centre Hospitalier de l’Université de Montréal (CHUM). She is recognized as a leader in addiction medicine in Canada. Her research contributed to a better understanding of factors impeding and facilitating harm reduction efforts among persons who inject drugs, including the role of prescription opioid injection on Hepatitis C transmission.
Agenda Item Image
Dr. Evan Cunningham
Research Fellow, Viral Hepatitis and Clinical Research Program
Kirby Institute

Injecting Risk Behaviours among People who Inject Drugs in an Australian Prison Setting, 2005-2014: The Hits-P Study

1:30 PM - 1:45 PM

Abstract

Speaker Presentation

Biography

Evan is a PhD candidate at the University of New South Wales in Sydney Australia. His research is focused on the transmission and treatment of HCV in people who inject drugs.
Dr Sumathi Ramachandran
Biologist
Centers For Disease Control And Prevention (cdc)

Implementation of Ghost for Detection of HCV Transmission Network by Tennessee Department of Health

1:45 PM - 2:00 PM

Abstract

Speaker Presentation

Biography

Sumathi Ramachandran has her PhD in Molecular Biology from Indian Institute of Science. She served as Research Faculty in the Emory School of Medicine. She has been with CDC for the last 13 years, and currently serves as Senior Biologist in Division of Viral Hepatitis. She has several career achievement awards, acts as Member of selection committees, Reviewer of scientific journals and mentored students and fellows. She has an exemplary publication record of more than 50 papers in reputed journals.
Mr. Emmanuel Fortier
PhD (cand.)
CHUM Research Centre

One-Year Injecting Frequency Trajectories as Predictors of Hepatitis C Acquisition: Findings from an Observational Cohort of People who Inject Drugs in Montréal, Canada

2:00 PM - 2:05 PM

Abstract

Speaker Presentation

Biography

Emmanuel Fortier is a MD/PhD student at the Université de Montréal. His research activities are conducted at the CHUM Research Centre (Montréal, Canada). He is supervised by Dr. Julie Bruneau (CHUM Research Centre) and co-supervised by Dr. Jason Grebely (Kirby Institute, Australia). His work revolves around the epidemiology of hepatitis C (HCV) infection and people who inject drugs (PWID), and could have important public health implications for the development of targeted prevention efforts in this population.
Dr Zoe Ward
Senior Research Associate In Infectious Disease Modelling
University Of Bristol

The Cost-Effectiveness of Needle and Syringe Provision in Preventing Transmission of Hepatitis C Virus in People who Inject Drugs

2:05 PM - 2:10 PM

Abstract

Biography

Dr Zoe Ward is a mathematical biologist interested in infectious disease dynamics and epidemiology. I am currently working on models of hepatitis C virus in populations of people who inject drugs and the impact of harm reduction policies and treatment.
Paula Tookey
Hcv Case Manager
South Riverdale Chc

From Client to Co-Worker: Peer Work within a Harm Reduction Hepatitis C Treatment Program in Toronto, Canada

2:10 PM - 2:15 PM

Abstract

Speaker Presentation

Biography

Paula Tookey is a Case Manager with Toronto Community Hep C Program where she co-facilitates two weekly treatment support groups and runs the community support worker training program for current/former clients. Paula has over twenty-five years of front line experience in community settings working with people experiencing homelessness, mental health issues and/or who use drugs/alcohol. Paula is passionate about harm reduction, community and program development, peer education and mentorship, and end of life issues.
Dr. Anthony Martinez
Associate Professor Of Medicine
University At Buffalo

Collaborative HCV Learning Model for Patients and Clinicians in Substance Use Disorder Clinics: 2016-2017 Findings on Knowledge and Perceptions

2:15 PM - 2:20 PM

Abstract

Speaker Presentation

Biography

Dr. Martinez is the medical director of Hepatology at the University at Buffalo. He completed an internship and residency in Internal Medicine at Boston University's affiliate in Providence Rhode Island. This was followed by a fellowship in Addiction Medicine and management of viral hepatitis at Weill Cornell Medical College where he later served on the faculty. He was affiliated with the University of California prior to his recruitment to the University at Buffalo to assume the directorship of Hepatology.
loading